PDGFRB and breast carcinoma: These show that IM inhibits breast cancer cell proliferation by inhibiting telomerase activity [68]; inhibits phosphorylation of PDGFR-β in MDA-MB-231 breast cancer cells [69]; and increases sensitivity of breast cancer cell lines to radiotherapy [31]in vitro.